Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism

Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism

BackgroundDrug-induced Parkinsonism (DIP) is a secondary Parkinsonism with limited research on its hippocampal structural changes. This study explores hippocampal subfield volumes in DIP compared to Parkinson’s disease (PD) and healthy controls (HCs), investigating correlations with cognitive (Montr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wei Zhou, MengYue Tang, Bo Cheng, Ling Sun, HongYu Lin, Yang Fan, Nian Liu, Shushan Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Drug-induced Parkinsonism Parkinson’s disease hippocampus subfields cognitive impairment
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2025.1566785/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer’s and Parkinson’s disease
by: Maud M. A. Bouwman, et al.
Published: (2025-05-01)

Impact of transcranial magnetic stimulation therapy on the volumes of amygdala and hippocampal subfields in patients with major depressive disorder
by: WANG Sirui, et al.
Published: (2025-04-01)

Hippocampal subfields in aging: Sex-specific trajectories in structure and hemodynamics
by: Jiaqi Wen, et al.
Published: (2025-08-01)

MWFNet: A multi-level wavelet fusion network for hippocampal subfield segmentation
by: Xinwei Li, et al.
Published: (2025-07-01)

Exploring the Correlation Between Sleep Chronotype and the Volumes of Subcortical Structures and Hippocampal Subfields in Young Healthy Population
by: Fahad H. Alhazmi
Published: (2025-03-01)

Cognitive impairment in patients with Parkinson’s disease
by: I. A. Zhukova, et al.
Published: (2010-08-01)

Identifying candidate genes associated with hippocampal dysfunction in a hemiparkinsonian rat model by transcriptomic profiling
by: Bohye Kim, et al.
Published: (2024-12-01)

Compound impact of cognitive and physical decline: A qualitative interview study of people with Parkinson's and cognitive impairment, caregivers and professionals
by: Jennifer S. Pigott, et al.
Published: (2024-02-01)

Anti-Ma-2 associated encephalitis presenting as slowly progressive dementia and cerebellar atrophy
by: Somdattaa Ray, et al.
Published: (2025-01-01)

A prospective study of cognitive impairment in Parkinson’s disease: clinical, neuropsychological, and neuroimaging correlates
by: Ahmed A. Gaballa, et al.
Published: (2025-06-01)

Hippocampal subfield and amygdala volumes are associated with difficulties in emotion regulation of depressed patients with a history of childhood maltreatment
by: Mónika Gálber, et al.
Published: (2025-08-01)

Impact of neuroprotective therapy on cognition and oxidative stress in the early stages of Parkinson’s disease
by: A. V. Demchenko, et al.
Published: (2021-12-01)

Correlation between change in choroid plexus volume and cognitive function in patients with Parkinson’s disease
by: ZHOU Suyi, et al.
Published: (2025-04-01)

A multi-modal study on cerebrovascular dysfunction in cognitive decline of de novo Parkinson’s disease
by: Hongwei Li, et al.
Published: (2025-01-01)

Etiology of parkinsonism in a Brazilian movement disorders clinic
by: FRANCISCO CARDOSO, et al.
Published: (1998-06-01)

Effects of propofol on the cognition and hippocampal N-methyl-D-aspartate subunits expression in an MPTP-induced Parkinson’s disease rat model
by: Ping Zhu, et al.
Published: (2025-06-01)

Cytoarchitecture of the Hippocampal Subfields CA3, CA4, and the Dentate Gyrus in Human Cerebrum: A Detailed Histological Analysis
by: Suvarna Anil Rampelliwar, et al.
Published: (2025-01-01)

White matter hyperintensity tissue property spatial variations as a function of cognitive status in Parkinson’s disease
by: Mariyemuguli Reheman, et al.
Published: (2025-05-01)

Association between Cognitive Impairment and Hippocampal Subfield Volumes in Multiple System Atrophy
by: Atsuhiko Sugiyama, et al.
Published: (2023-01-01)

Distinctive cognitive phenotypes in Parkinson’s disease patients with GBA mutations and without dementia: a multicentre cross-sectional retrospective study
by: Chiara Longo, et al.
Published: (2025-01-01)

Modeling and validation of wearable sensor-based gait parameters in Parkinson’s disease patients with cognitive impairment
by: Guo Hong, et al.
Published: (2025-07-01)

Microbiome signatures of virulence in the oral-gut-brain axis influence Parkinson’s disease and cognitive decline pathophysiology
by: Frederick Clasen, et al.
Published: (2025-12-01)

Current research status of imaging markers for cognitive impairment in Parkinson′s disease
by: CAO Mingming, et al.
Published: (2025-05-01)

Subtyping Early Parkinson’s Disease by Mapping Cognitive Profiles to Brain Atrophy with Visual MRI Ratings
by: Tania Álvarez-Avellón, et al.
Published: (2025-07-01)

Unusual motor and non-motor symptoms and signs in the early stage of Parkinson’s disease
by: Hélio A. G. Teive, et al.

Neuroscience-informed nomogram model for early prediction of cognitive impairment in Parkinson's disease
by: Sudharshan Putha, et al.
Published: (2025-06-01)

Demographic and Clinical Profile of Patients with Parkinsonism in Northwestern Nigeria
by: Halimat Hassan Amin, et al.
Published: (2024-10-01)

Clinical approach to monogenic Parkinson’s disease
by: Manu S. Girija, et al.
Published: (2025-01-01)

Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson’s disease
by: Yud Dan Liu, et al.
Published: (2025-07-01)

The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson’s Disease
by: Yu X, et al.
Published: (2025-03-01)

Cognition‐Associated Changes in Retinal Thickness Relate to Limbic and Temporal Cortical Atrophy in Parkinson's Disease
by: Kerstin Schweyer, et al.
Published: (2025-05-01)

Capturing the Abnormal Brain Network Activity in Early Parkinsons Disease With Mild Cognitive Impairment Based on Dynamic Functional Connectivity
by: Guosheng Yi, et al.
Published: (2023-01-01)

Mapping Nationwide Subfield Division Dynamics in Saudi Arabia Using Temporal Patterns of Sentinel-2 NDVI and Machine Learning
by: Ting Li, et al.
Published: (2025-01-01)

Pain in Parkinson's disease Dor na doença de Parkinson
by: Grace Helena Letro, et al.
Published: (2009-09-01)

Depressive symptoms and perception of quality of life in Parkinson's disease Sintomas depressivos e percepção da qualidade de vida na doença de Parkinson
by: Paula Scalzo, et al.
Published: (2009-06-01)

Fluency in Parkinson?s disease: disease duration, cognitive status and age
by: Natalia Casagrande Brabo, et al.
Published: (2014-05-01)

Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study
by: Sotirios Grigoriou, et al.
Published: (2025-05-01)

Potential biofluid markers for cognitive impairment in Parkinson’s disease
by: Jieyu Chen, et al.
Published: (2026-01-01)

Alterações do olfato na doença de Parkinson Olfactory dysfunction in Parkinson's disease
by: Lucas Barasnevicius Quagliato, et al.
Published: (2007-09-01)

Curcumin as a potential therapeutic agent for Parkinson’s disease: a systematic review
by: Yu-Hsien Chang
Published: (2025-04-01)